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Monitoring of services in the National Health Service in
England is framed around clinical outcomes, safety and
patient experience.
A system of dashboards is being developed to provide
monthly information about specialised services. The
initial pilot has included a set of key information about
services to patients with haemophilia and cystic fibrosis,
for example the proportion of patients on home treat-
ment (haemophilia) or the proportion admitted to a
ward with specialist staff (cystic fibrosis). Data items
were agreed by clinicians as relevant and important. The
information is available from every provider.
In the highly specialised services for very rare disease
(prevalence less than 1 in 100 000) the dashboard runs
annually, not monthly, and is based on long experience
[1]. Outcome monitoring is particularly well developed
for sold organ transplant, with agreed protocols for
investigating and responding to statistical outliers.
Quality of life measures are used in some services
such as epidermolysis bullosa and neurofibromatosis
type 2 [2], but there is not enough experience with
these measures to compare different hospitals or to
track trends.
Safety incidents such as ‘never’ events are rare; they
are reported and investigated immediately.
Patient experience is monitored through surveys and
close contact with patient organisations.
A key mechanism for monitoring quality in the highly
specialised services is an annual meeting. Attendance by
all providers of the service is mandatory. Clinical outcome
data is presented on all patients treated, and interesting or
informative cases are discussed by the clinical teams. The
meeting provides an excellent forum for peer review,
exchange of clinical experience and learning.
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